Gyeyeong Kong
Gyeyeong Kong
1Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
2Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
1,2,
Hyunji Lee
Hyunji Lee
1Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
2Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
1,2,
Quangdon Tran
Quangdon Tran
1Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
2Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
1,2,
Chaeyeong Kim
Chaeyeong Kim
1Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
2Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
1,2,✉,
Jisoo Park
Jisoo Park
1Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
2Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
3Department of Life Science, Hyehwa Liberal Arts College, LINC Plus Project Group, Daejeon University, Daejeon, South Korea
1,2,3,✉,
So Hee Kwon
So Hee Kwon
4College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, South Korea
4,
Seon-Hwan Kim
Seon-Hwan Kim
5Department of Neurosurgery, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
5,*,
Jongsun Park
Jongsun Park
1Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
2Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
1,2,*
1Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
2Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
3Department of Life Science, Hyehwa Liberal Arts College, LINC Plus Project Group, Daejeon University, Daejeon, South Korea
4College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, South Korea
5Department of Neurosurgery, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
Edited and reviewed by:
Yong Teng, Augusta University, Augusta, GA, United States
✉*Correspondence: Seon-Hwan Kim, neons@cnu.ac.kr; Jongsun Park, insulin@cnu.ac.kr
This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Molecular Biosciences
Received 2020 Dec 8; Accepted 2021 Jan 22; Collection date 2021.
Keywords: AMACR, branched-chain fatty acid, cancer development, B-oxidation, lipid metabolism
Copyright © 2021 Kong, Lee, Tran, Kim, Park, Kwon, Kim and Park.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.